跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEP-1
首页
药物
PEP-1
PEP-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS PROMOTING GROWTH OF PERIPHERAL NERVOUS TISSUE
EP 4228661 A4
申请人: MAYO FOUND MEDICAL EDUCATION & RES
优先权: 2020
EP
US
WO
3 件公开
Method and applications of peptide-mediated mitochondrial delivery system
US 8648034 B2
申请人: CHANG JUI-CHIH
优先权: 2011
US
3 件公开
Self-assembling drug amphiphiles and methods for synthesis and use
US 9180203 B2
申请人: UNIV JOHNS HOPKINS
优先权: 2013
US
3 件公开
uPAR selective contrast agent for magnetic resonance imaging
EP 1902734 A1
申请人: DEUTSCHES KREBSFORSCH
优先权: 2006
EP
WO
2 件公开
Clostridium perfringens bacteriophage Clo-PEP-1 and use thereof for inhibiting proliferation of clostridium perfringens
US 10028984 B2
申请人: INTRON BIOTECHNOLOGY INC
优先权: 2014
CN
US
2 件公开
Clostridium perfringens bacteriophage Clo-PEP-2 and use for inhibiting Clostridium perfringens proliferation of same
US 11529406 B2
申请人: INTRON BIOTECHNOLOGY INC
优先权: 2017
CN
US
2 件公开
Methods and compositions for modulating C5-a-mediated inflammatory responses
US 2006063701 A1
申请人: OKADA HIDECHIKA
优先权: 2005
US
2 件公开
Fusion protein comprising FK506 binding protein and DNA encoding the same
US 7902346 B2
申请人: IND ACADEMIC COOP
优先权: 2006
US
2 件公开
Pro-angiogenic fragments of prominin-1 and uses thereof
US 9090707 B2
申请人: ADINI AVNER
优先权: 2011
US
2 件公开
The pET15b-PEP-1-Cat plasmid and its construction and PEP-1-CAT fusion protein and its expression
CN 1974774 A
申请人: WANG JIANING
优先权: 2005
CN
第 1 / 7 页
上一页
下一页
药物
反馈